Page last updated: 2024-08-24

atorvastatin and vildagliptin

atorvastatin has been researched along with vildagliptin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Lao, VWN; Lau, WY; Lee, KF; Mak, MWH; Wong, VTL; Yip, HLK	1

Other Studies

1 other study(ies) available for atorvastatin and vildagliptin

Article	Year
Immune-mediated necrotising myopathy is a rare statin-associated adverse effect: a case report. Hong Kong medical journal = Xianggang yi xue za zhi, 2020, Volume: 26, Issue:5 Topics: Atorvastatin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Female; Gliclazide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Middle Aged; Myotoxicity; Vildagliptin	2020

Article

Year

Immune-mediated necrotising myopathy is a rare statin-associated adverse effect: a case report.

Hong Kong medical journal = Xianggang yi xue za zhi, 2020, Volume: 26, Issue:5

Topics: Atorvastatin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Female; Gliclazide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Middle Aged; Myotoxicity; Vildagliptin

2020